ANDREA GIANATTI

Dr. ANDREA GIANATTI

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2020 in Liver International
Verified
Journal Article
Closed access
ASAurelio Sonzogni
Aurelio Sonzogni
GPGiulia Previtali
Giulia Previtali
MSMichela Seghezzi
Michela Seghezzi
MAMaria Grazia Alessio
Maria Grazia Alessio
AGANDREA GIANATTI
ANDREA GIANATTI
MNManuela Nebuloni
Manuela Nebuloni

18 November 2020 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
EBEnrico Brunetta
Enrico Brunetta
MFMarco Folci
Marco Folci
BBBarbara Bottazzi
Barbara Bottazzi
MSMaria De Santis
Maria De Santis
GGGiuseppe Gritti
Giuseppe Gritti
Alberto MantovaniAlberto Mantovani
Alberto Mantovani

22 April 2020 in medRxiv
Verified
Preprint
Open access
PDF file
LCLuca Carsana
Luca Carsana
ASaurelio sonzogni
aurelio sonzogni
ANAhmed Nasr
Ahmed Nasr
RRRoberta Simona Rossi
Roberta Simona Rossi
APAlessandro Pellegrinelli
Alessandro Pellegrinelli
MNManuela Nebuloni
Manuela Nebuloni
Importance: The analysis of lung tissues of patients with COVID-19 may help understand pathogenesis and clinical outcomes in this life-threatening respiratory illness. Objective: To determine the histological patterns in lung tissue of patients with severe COVID-19. Design and participants: Lungs tissues of 38 cases who died for COVID-19 in two hospital of Northern Italy were systematically analysed. Hematoxylin-eosin staining, immunohistochemistry for the inflammatory infiltrate and cellular components, electron microscopy were performed. Results: The features of the exudative and proliferative phases of Diffuse Alveolar Disease (DAD) were found: capillary congestion, necrosis of pneumocytes, hyaline membrane, interstitial oedema, pneumocyte hyperplasia and reactive atypia, platelet-fibrin thrombi. The inflammatory infiltrate was composed by macrophages in alveolar lumens and lymphocytes mainly in the interstice. Electron microscopy revealed viral particles in the cytoplasm of pneumocytes. Conclusions and relevance: The predominant pattern of lung lesions in COVID-19 patients is DAD, as described for the other two coronavirus that infect humans, SARS-CoV and MERS-CoV. Hyaline membrane formation and pneumocyte atypical hyperplasia are frequently found. The main relevant finding is the presence of platelet-fibrin thrombi in small arterial vessels; this important observation fits into the clinical context of coagulopathy which dominates in these patients and which is one of the main targets of therapy.

14 January 2021 in Cancers
Verified
Journal Article
Open access
PDF file
SCSimona Crosta
Simona Crosta
Renzo BoldoriniRenzo Boldorini
Renzo Boldorini
FBFrancesca Bono
Francesca Bono
VBVirginia Brambilla
Virginia Brambilla
EDEmanuele Dainese
Emanuele Dainese
FPFabio Pagni
Fabio Pagni
Immune checkpoint inhibitors for blocking the programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) axis are now available for squamous cell carcinoma of the head and neck (HNSCC) in relapsing and/or metastatic settings. In this work, we compared the resulting combined positive score (CPS) of PD-L1 using alternative methods adopted in routine clinical practice and determined the level of diagnostic agreement and inter-observer reliability in this setting. The study applied 5 different protocols on 40 tissue microarrays from HNSCC. The error rate of the individual protocols ranged from a minimum of 7% to a maximum of 21%, the sensitivity from 79% to 96%, and the specificity from 50% to 100%. In the intermediate group (1 ≤ CPS < 20), the majority of errors consisted of an underestimation of PD-L1 expression. In strong expressors, 5 out of 14 samples (36%) were correctly evaluated by all the protocols, but no protocol was able to correctly identify all the “strong expressors”. The overall inter-observer agreement in PD-L1 CPS reached 87%. The inter-observer reliability was moderate, with an ICC of 0.774 (95% CI (0.651; 0.871)). In conclusion, our study showed moderate interobserver reliability among different protocols. In order to improve the performances, adequate specific training to evaluate PD-L1 by CPS in the HNSCC setting should be coordinated.

15 April 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
DMDenise Morotti
Denise Morotti
MCMassimiliano Cadamuro
Massimiliano Cadamuro
ERElena Rigoli
Elena Rigoli
ASaurelio sonzogni
aurelio sonzogni
AGANDREA GIANATTI
ANDREA GIANATTI
David A. SchwartzDavid A. Schwartz
David A. Schwartz
A small number of neonates delivered to women with SARS-CoV-2 infection have been found to become infected through intrauterine transplacental transmission. These cases are associated with a group of unusual placental pathology abnormalities that include chronic histiocytic intervillositis, syncytiotrophoblast necrosis, and positivity of the syncytiotrophoblast for SARS-CoV-2 antigen or RNA. Hofbauer cells constitute a heterogeneous group of immunologically active macrophages that have been involved in transplacental infections that include such viral agents as Zika virus and human immunodeficiency virus. The role of Hofbauer cells in placental infection with SARS-CoV-2 and maternal-fetal transmission is unknown. This study uses molecular pathology techniques to evaluate the placenta from a neonate infected with SARS-CoV-2 via the transplacental route to determine whether Hofbauer cells have evidence of infection. We found that the placenta had chronic histiocytic intervillositis and syncytiotrophoblast necrosis, with the syncytiotrophoblast demonstrating intense positive staining for SARS-CoV-2. Immunohistochemistry using the macrophage marker CD163, SARS-CoV-2 nucleocapsid protein, and double staining for SARS-CoV-2 with RNAscope and anti-CD163 antibody, revealed that no demonstrable virus could be identified within Hofbauer cells, despite these cells closely approaching the basement membrane zone of the infected trophoblast. Unlike some other viruses, there was no evidence from this transmitting placenta for infection of Hofbauer cells with SARS-CoV-2.

18 February 2023 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
IGIlaria Girolami
Ilaria Girolami
SMStefano Marletta
Stefano Marletta
Vincenzo FiorentinoVincenzo Fiorentino
Vincenzo Fiorentino
SBSimonetta Battocchio
Simonetta Battocchio
BCBruna Cerbelli
Bruna Cerbelli
Albino EccherAlbino Eccher
Albino Eccher
Background: Programmed death-ligand 1 (PD-L1) checkpoint inhibitors represent a mainstay of therapy in head and neck squamous cell cancer (HNSCC). However, little is known about the influence of combined therapy on PD-L1 expression. The study aims to gather evidence on this topic. Methods: A systematic search was carried out in electronic databases Pubmed-MEDLINE and Embase to retrieve studies on the comparison of PD-L1 expression before and after conventional therapy. Data were extracted and a quantitative analysis with pooled odds ratios (ORs) was performed when applicable. Results: Of 5688 items, 15 were finally included. Only a minority of studies assessed PD-L1 with the recommended combined positive score (CPS). The results are highly heterogeneous, with some studies reporting an increase in PD-L1 expression and others reporting a decrease. Three studies allowed for quantitative analysis and showed a pooled OR of 0.49 (CI 0.27–0.90). Conclusions: From the present evidence, a clear conclusion towards an increase or decrease in PD-L1 expression after combined therapy cannot be drawn, but even with few studies available, a trend towards an increase in expression in tumor cells at a cutoff of 1% can be noted in patients undergoing platinum-based therapy. Future studies will provide more robust data on the effect of combined therapy on PD-L1 expression.